Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?

The antiphospholipid syndrome (APS) is characterized by the development of venous and/or arterial thrombosis and pregnancy morbidity in patients with persistent antiphospholipid antibodies (aPL). Catastrophic antiphospholipid syndrome (CAPS) is a life-threatening form of APS occurring in about 1% of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mormile, Ilaria, Granata, Francescopaolo, Punziano, Alessandra, de Paulis, Amato, Rossi, Francesca Wanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911562/
https://www.ncbi.nlm.nih.gov/pubmed/33535377
http://dx.doi.org/10.3390/biomedicines9020132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911562/
https://www.ncbi.nlm.nih.gov/pubmed/33535377
http://dx.doi.org/10.3390/biomedicines9020132

Ejemplares similares